BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11238837)

  • 21. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
    van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
    J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
    Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
    J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genotyping diagnosis of acyclovir resistant herpes simplex virus].
    Frobert E; Thouvenot D; Lina B; Morfin F
    Pathol Biol (Paris); 2007 Dec; 55(10):504-11. PubMed ID: 17920786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.
    Morfin F; Thouvenot D; Aymard M; Souillet G
    J Med Virol; 2000 Oct; 62(2):247-50. PubMed ID: 11002255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
    Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
    J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines.
    Balzarini J; Ostrowski T; Goslinski T; De Clercq E; Golankiewicz B
    Gene Ther; 2002 Sep; 9(17):1173-82. PubMed ID: 12170381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients.
    Morfin F; Souillet G; Bilger K; Ooka T; Aymard M; Thouvenot D
    J Infect Dis; 2000 Jul; 182(1):290-3. PubMed ID: 10882609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues.
    Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
    Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and genotypic characterization of induced acyclovir-resistant clinical isolates of herpes simplex virus type 1.
    Hussin A; Md Nor NS; Ibrahim N
    Antiviral Res; 2013 Nov; 100(2):306-13. PubMed ID: 24055837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
    Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
    Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
    van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
    J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium].
    Wang B; Weng J
    Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiviral sensitivity of herpes simplex virus in immunocompromised patients].
    Illán H; Jacob N; Maiolo E; Cisterna D; Schiavelli R; Freire MC
    Rev Argent Microbiol; 2004; 36(2):88-91. PubMed ID: 15470869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
    Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
    J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents.
    Azab W; Tsujimura K; Kato K; Arii J; Morimoto T; Kawaguchi Y; Tohya Y; Matsumura T; Akashi H
    Antiviral Res; 2010 Feb; 85(2):389-95. PubMed ID: 19931566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.